Guide for Milk Substitutes in Cow’s Milk Allergy

pdfASCIA HP Guide for Milk Substitutes in Cow’s Milk Allergy193.19 KB

ASCIA Guide for Milk Substitutes in Cow's Milk AllergyBreastfeeding is recommended for the multiple benefits it brings to both the mother and child. If breastfeeding is not possible, this document can assist health professionals in recommending substitute milks when an infant has cow’s milk allergy. This document also provides guidance about safe, nutritionally equivalent alternatives if a particular specialised formula is not available due to supply issues.

Exclusion of cow’s milk from a breastfeeding mother’s diet is not necessarily required in cow’s milk allergy, and should be discussed with a specialist, and supervised by a dietitian.

This information has been prepared and reviewed by the ASCIA dietitians and paediatric committees.

Commercial names and suppliers of specialised infant formula in Australia and New Zealand, and the method for their supply is provided for ease of reference.

For Pharmaceutical Benefits Scheme (PBS) and Pharmac Special Authority (PSA) item numbers for formula products listed in this document go to or

Table 1: Abbreviations used in this document

AAF - Amino acid formula

FPIAP - Food Protein Induced Allergic Proctocolitis

CMA – Cow’s milk allergy

FPIES - Food Protein Induced Enterocolitis Syndrome

eHF – Extensively hydrolysed formula

OTC - Available over the counter

EoE – Eosinophilic oesophagitis

PBS – Pharmaceutical Benefits Scheme (AU)

FPE - Food Protein Enteropathy

PSA - Pharmac Special Authority (NZ)

Table 2: Commercially available specialised infant formula suitable for cow's milk allergy (CMA)

Suitable formula
(see table 3 for indications)

Brand names and suppliers


Soy based infant formula

  • Karicare® Soy (Nutricia®)
  • S-26 Gold® Soy (Aspen)


Extensively hydrolysed formula (eHF)

  • Aptamil® Allerpro SYNEOTM 1, 2 and 3 (Nutricia®) - contains lactose


Extensively hydrolysed formula (eHF)

  • Alfaré® (Nestlé®)
  • Aptamil® Gold+ Pepti-Junior® (Nutricia®)

PBS and PSA listed (prescription required)

Rice protein based formula

  • Novalac Allergy (Aspen Australia)


Amino acid based formula (AAF) for infants <12 months of age

  • Neocate® Gold, LCP and SYNEOTM (Nutricia®)
  • Elecare® (Abbott)
  • Elecare® LCP (Abbott)
  • Alfamino® (Nestlé®)

PBS and PSA listed (prescription required)

Amino acid based formula (AAF) for children >12 months of age

  • Neocate® Junior (Nutricia®)
  • Neocate® Junior Vanilla (Nutricia®)
  • Elecare® Vanilla (Abbott)
  • Alfamino® Junior (Nestlé®)
  • Essential Care Jr (Cortex Health)*

PBS and PSA listed (prescription required)


* Not currently PSA listed

Infant formula NOT recommended for cow's milk allergy (CMA)

The following types of formula are NOT recommended for infants with cow’s milk allergy:

  • Standard infant formula including anti-regurgitation, lactose free, organic, newborn, and follow on.
  • Goat milk based infant formula.
  • Other mammal milks and formula.
  • A2 formula.

Table 3: Specialised formula and indications in cow's milk allergy (CMA)

Type of Allergy

First choice

Second choice

(if first not tolerated)

Third choice

(if second not tolerated)

(IgE mediated) CMA 
(not anaphylaxis)

  • eHF (<6 months) or
  • Rice protein based formula*


  • Soy formula** (>6 months) or
  • Rice protein based formula*




  • AAF or
  • Soy formula** (>6 months) or
  • Rice protein based formula*


  • eHF (<6 months) or
  • Rice protein based formula*


  • Soy formula (>6 months and already soy-tolerant/after medically supervised soy introduction), or
  • Rice protein based formula*



Non IgE mediated CMA

  • eHF (<6 months) or
  • Rice protein based formula*


  • Soy formula** (>6 months and growing well), or
  • Rice protein based formula*




  • AAF

Atopic dermatitis (eczema) alone is not an indication for specialised infant formula.

* Unless allergic to rice.

** Unless allergic to soy.

Soy is offered as an option for IgE-mediated CMA and anaphylaxis based on expert opinion, and review of the literature which presents very limited evidence of IgE mediated clinical reactions to soy in children with IgE-mediated cow’s milk allergy.

(Adapted from Kemp et al.,2008)

Guidance regarding specialised formula substitutes for cow’s milk allergy (CMA)

If an infant’s usual formula is unavailable, use table 3 to select suitable substitutes. The most straightforward approach is to select a product from the same group that the child is already on (e.g. substitute one eHF for another eHF).

Recommendations for a substitute formula should involve a review of factors that led to the initial choice, and any change in clinical history. For example:

  • A thriving child with non-anaphylactic IgE-mediated reactions to cow’s milk formula was established on eHF due to age being less than six months, but is now older than six months, therefore soy formula should be considered.

When AAF for children older than 12 months is required, but is unavailable:

  • A paediatric allergy dietitian should be consulted to assist with modifying the recipe for a substitute AAF.
  • For all formula changes, recipe instructions should be reviewed with the family, as scoop to water ratios can vary substantially.

For children older than 12 months, calcium fortified soy milk is an appropriate replacement for soy formula, if they are growing well and eating a wide range of family foods.

For children with cow’s milk and soy allergies:

  • Most plant based milk replacement products that are not calcium fortified are too low in protein, fat, and calcium. Therefore, they are not nutritionally adequate for children under two years of age, unless growth and nutrition have been assessed carefully.
  • Children under four years of age only need 400-500 mL of calcium fortified plant based milk replacements a day to meet their calcium requirements. Larger quantities can reduce appetite, nutritional intake, and growth.

Referral of infants and children with CMA to a paediatric allergy dietitian is recommended to assess nutritional needs.

© ASCIA 2022

ASCIA is the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand.

ASCIA resources are based on published literature and expert review, however, they are not intended to replace medical advice. The content of ASCIA resources is not influenced by any commercial organisations.

For more information go to

To donate to immunology/allergy research go to

Mod ASCIA Member
Donate to AIFA
go to NAC website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia